Laboratory Medicine ›› 2024, Vol. 39 ›› Issue (1): 53-59.DOI: 10.3969/j.issn.1673-8640.2024.01.010
Previous Articles Next Articles
TAN Haiyan, JIANG Yurong
Received:
2023-05-22
Revised:
2023-10-19
Online:
2024-01-30
Published:
2024-03-04
CLC Number:
TAN Haiyan, JIANG Yurong. Role of Group B Streptococcus detection in pregnant women combined with fetal cord blood neutrophil CD64 index for predicting neonatal infection with premature rupture of membranes[J]. Laboratory Medicine, 2024, 39(1): 53-59.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2024.01.010
项目 | 例数 | 胎龄/周 | 性别 | 出生体重/kg | 分娩方式 | 前置胎盘 | |||
---|---|---|---|---|---|---|---|---|---|
男/ | 女/ | 自然分娩/[例(%)] | 剖宫产/ | 是/ | 否/ | ||||
[例(%)] | [例(%)] | [例(%)] | [例(%)] | [例(%)] | |||||
匹配前 | |||||||||
感染组 | 48 | 38.56±1.68 | 26(54.17) | 22(45.83) | 3.25±0.56 | 17(35.42) | 31(64.58) | 7(14.58) | 41(85.42) |
未感染组 | 122 | 38.24±0.99 | 60(49.18) | 62(50.82) | 3.41±0.39 | 42(34.43) | 80(65.57) | 16(13.11) | 106(86.89) |
统计值 | 1.536 | 0.343 | 2.114 | 0.015 | 0.064 | ||||
P值 | 0.126 | 0.558 | 0.036 | 0.903 | 0.801 | ||||
匹配后 | |||||||||
感染组 | 48 | 38.56±1.68 | 26(54.17) | 22(45.83) | 3.25±0.56 | 17(35.42) | 31(64.58) | 7(14.58) | 41(85.42) |
未感染组 | 48 | 38.37±1.53 | 25(52.08) | 23(47.92) | 3.31±0.76 | 19(39.58) | 29(60.42) | 10(20.83) | 38(79.17) |
统计值 | 0.579 | 0.042 | 0.44 | 0.178 | 0.643 | ||||
P值 | 0.564 | 0.838 | 0.661 | 0.673 | 0.423 | ||||
项目 | PROM到入院时间 | PROM到分娩时间 | 绒毛膜羊膜炎 | ||||||
≥15 h/ | <15 h/ | ≥24 h/ | <24 h/ | 是/[例(%)] | 否/[例(%)] | ||||
[例(%)] | [例(%)] | [例(%)] | [例(%)] | ||||||
匹配前 | |||||||||
感染组 | 29(60.42) | 19(39.58) | 20(41.67) | 28(58.33) | 13(22.92) | 35(77.08) | |||
未感染组 | 31(25.41) | 91(74.59) | 21(17.21) | 101(82.79) | 10(8.20) | 112(91.80) | |||
统计值 | 18.485 | 11.255 | 10.503 | ||||||
P值 | <0.001 | 0.001 | 0.001 | ||||||
匹配后 | |||||||||
感染组 | 29(60.42) | 19(39.58) | 20(41.67) | 28(58.33) | 13(22.92) | 35(77.08) | |||
未感染组 | 20(41.67) | 28(58.33) | 11(22.92) | 37(77.08) | 4(8.33) | 44(91.67) | |||
统计值 | 3.376 | 3.859 | 5.79 | ||||||
P值 | 0.066 | 0.049 | 0.016 | ||||||
项目 | 绒毛膜羊膜炎致病菌 | GBS阳性 | |||||||
GBS/ [例(%)] | 大肠埃希菌/ [例(%)] | 粪肠球菌/ [例(%)] | 金黄色葡萄球菌/ [例(%)] | 是/[例(%)] | 否/[例(%)] | ||||
匹配前 | 4(8.33) | 4(8.33) | 3(6.25) | 2(4.17) | |||||
感染组 | 3(2.46) | 2(1.64) | 2(1.64) | 3(2.46) | 14(29.17) | 34(70.83) | |||
未感染组 | 4(3.28) | 118(96.72) | |||||||
统计值 | 0.832 | 24.385 | |||||||
P值 | 0.842 | <0.001 | |||||||
匹配后 | 4(8.33) | 4(8.33) | 3(6.25) | 2(4.17) | |||||
感染组 | 2(4.17) | 1(2.08) | 0(0.00) | 1(2.08) | 14(29.17) | 34(70.83) | |||
未感染组 | 0(0.00) | 48(100.00) | |||||||
统计值 | 1.438 | 16.39 | |||||||
P值 | 0.697 | <0.001 | |||||||
项目 | 绒毛膜羊膜炎伴GBS阳性 | 阴道指检次数 | 产前使用抗菌药物 | ||||||
是/[例(%)] | 否/[例(%)] | ≥6次/[例(%)] | <6次/[例(%)] | 是/[例(%)] | 否/[例(%)] | ||||
匹配前 | |||||||||
感染组 | 7(14.58) | 6(12.50) | 27(56.25) | 21(43.75) | 10(20.83) | 38(79.17) | |||
未感染组 | 3(2.46) | 7(5.74) | 25(20.49) | 97(79.51) | 9(7.38) | 113(92.62) | |||
统计值 | 1.308 | 20.745 | 6.283 | ||||||
P值 | 0.25 | <0.001 | 0.012 | ||||||
匹配后 | |||||||||
感染组 | 7(14.58) | 6(12.50) | 27(56.25) | 21(43.75) | 10(20.83) | 38(79.17) | |||
未感染组 | 0(0.00) | 4(8.33) | 15(31.25) | 33(68.75) | 3(6.25) | 45(93.75) | |||
统计值 | 3.662 | 6.095 | 4.36 | ||||||
P值 | 0.056 | 0.014 | 0.037 | ||||||
项目 | 5 min Apgar评分< 7分 | 羊水污染 | 白细胞计数/ | CRP/ | CD64 | ||||
是/[例(%)] | 否/[例(%)] | 是/[例(%)] | 否/[例(%)] | (×109/L) | (mg·L-1) | ||||
匹配前 | |||||||||
感染组 | 29(60.42) | 19(39.58) | 14(29.17) | 34(70.83) | 13.52±4.71 | 3.85±1.61 | 0.46±0.16 | ||
未感染组 | 18(14.75) | 104(85.25) | 6(4.92) | 116(95.08) | 12.23±4.06 | 4.32±2.48 | 0.32±0.12 | ||
统计值 | 35.906 | 19.512 | 1.781 | 1.215 | 6.205 | ||||
P值 | <0.001 | <0.001 | 0.077 | 0.226 | <0.001 | ||||
匹配后 | |||||||||
感染组 | 29(60.42) | 19(39.58) | 14(29.17) | 34(70.83) | 13.52±4.71 | 3.85±1.61 | 0.46±0.16 | ||
未感染组 | 10(20.83) | 38(79.17) | 1(2.08) | 47(97.92) | 12.42±3.99 | 4.29±2.50 | 0.31±0.11 | ||
统计值 | 15.59 | 13.353 | 1.235 | 1.025 | 5.352 | ||||
P值 | <0.001 | <0.001 | 0.22 | 0.308 | <0.001 |
项目 | 例数 | 胎龄/周 | 性别 | 出生体重/kg | 分娩方式 | 前置胎盘 | |||
---|---|---|---|---|---|---|---|---|---|
男/ | 女/ | 自然分娩/[例(%)] | 剖宫产/ | 是/ | 否/ | ||||
[例(%)] | [例(%)] | [例(%)] | [例(%)] | [例(%)] | |||||
匹配前 | |||||||||
感染组 | 48 | 38.56±1.68 | 26(54.17) | 22(45.83) | 3.25±0.56 | 17(35.42) | 31(64.58) | 7(14.58) | 41(85.42) |
未感染组 | 122 | 38.24±0.99 | 60(49.18) | 62(50.82) | 3.41±0.39 | 42(34.43) | 80(65.57) | 16(13.11) | 106(86.89) |
统计值 | 1.536 | 0.343 | 2.114 | 0.015 | 0.064 | ||||
P值 | 0.126 | 0.558 | 0.036 | 0.903 | 0.801 | ||||
匹配后 | |||||||||
感染组 | 48 | 38.56±1.68 | 26(54.17) | 22(45.83) | 3.25±0.56 | 17(35.42) | 31(64.58) | 7(14.58) | 41(85.42) |
未感染组 | 48 | 38.37±1.53 | 25(52.08) | 23(47.92) | 3.31±0.76 | 19(39.58) | 29(60.42) | 10(20.83) | 38(79.17) |
统计值 | 0.579 | 0.042 | 0.44 | 0.178 | 0.643 | ||||
P值 | 0.564 | 0.838 | 0.661 | 0.673 | 0.423 | ||||
项目 | PROM到入院时间 | PROM到分娩时间 | 绒毛膜羊膜炎 | ||||||
≥15 h/ | <15 h/ | ≥24 h/ | <24 h/ | 是/[例(%)] | 否/[例(%)] | ||||
[例(%)] | [例(%)] | [例(%)] | [例(%)] | ||||||
匹配前 | |||||||||
感染组 | 29(60.42) | 19(39.58) | 20(41.67) | 28(58.33) | 13(22.92) | 35(77.08) | |||
未感染组 | 31(25.41) | 91(74.59) | 21(17.21) | 101(82.79) | 10(8.20) | 112(91.80) | |||
统计值 | 18.485 | 11.255 | 10.503 | ||||||
P值 | <0.001 | 0.001 | 0.001 | ||||||
匹配后 | |||||||||
感染组 | 29(60.42) | 19(39.58) | 20(41.67) | 28(58.33) | 13(22.92) | 35(77.08) | |||
未感染组 | 20(41.67) | 28(58.33) | 11(22.92) | 37(77.08) | 4(8.33) | 44(91.67) | |||
统计值 | 3.376 | 3.859 | 5.79 | ||||||
P值 | 0.066 | 0.049 | 0.016 | ||||||
项目 | 绒毛膜羊膜炎致病菌 | GBS阳性 | |||||||
GBS/ [例(%)] | 大肠埃希菌/ [例(%)] | 粪肠球菌/ [例(%)] | 金黄色葡萄球菌/ [例(%)] | 是/[例(%)] | 否/[例(%)] | ||||
匹配前 | 4(8.33) | 4(8.33) | 3(6.25) | 2(4.17) | |||||
感染组 | 3(2.46) | 2(1.64) | 2(1.64) | 3(2.46) | 14(29.17) | 34(70.83) | |||
未感染组 | 4(3.28) | 118(96.72) | |||||||
统计值 | 0.832 | 24.385 | |||||||
P值 | 0.842 | <0.001 | |||||||
匹配后 | 4(8.33) | 4(8.33) | 3(6.25) | 2(4.17) | |||||
感染组 | 2(4.17) | 1(2.08) | 0(0.00) | 1(2.08) | 14(29.17) | 34(70.83) | |||
未感染组 | 0(0.00) | 48(100.00) | |||||||
统计值 | 1.438 | 16.39 | |||||||
P值 | 0.697 | <0.001 | |||||||
项目 | 绒毛膜羊膜炎伴GBS阳性 | 阴道指检次数 | 产前使用抗菌药物 | ||||||
是/[例(%)] | 否/[例(%)] | ≥6次/[例(%)] | <6次/[例(%)] | 是/[例(%)] | 否/[例(%)] | ||||
匹配前 | |||||||||
感染组 | 7(14.58) | 6(12.50) | 27(56.25) | 21(43.75) | 10(20.83) | 38(79.17) | |||
未感染组 | 3(2.46) | 7(5.74) | 25(20.49) | 97(79.51) | 9(7.38) | 113(92.62) | |||
统计值 | 1.308 | 20.745 | 6.283 | ||||||
P值 | 0.25 | <0.001 | 0.012 | ||||||
匹配后 | |||||||||
感染组 | 7(14.58) | 6(12.50) | 27(56.25) | 21(43.75) | 10(20.83) | 38(79.17) | |||
未感染组 | 0(0.00) | 4(8.33) | 15(31.25) | 33(68.75) | 3(6.25) | 45(93.75) | |||
统计值 | 3.662 | 6.095 | 4.36 | ||||||
P值 | 0.056 | 0.014 | 0.037 | ||||||
项目 | 5 min Apgar评分< 7分 | 羊水污染 | 白细胞计数/ | CRP/ | CD64 | ||||
是/[例(%)] | 否/[例(%)] | 是/[例(%)] | 否/[例(%)] | (×109/L) | (mg·L-1) | ||||
匹配前 | |||||||||
感染组 | 29(60.42) | 19(39.58) | 14(29.17) | 34(70.83) | 13.52±4.71 | 3.85±1.61 | 0.46±0.16 | ||
未感染组 | 18(14.75) | 104(85.25) | 6(4.92) | 116(95.08) | 12.23±4.06 | 4.32±2.48 | 0.32±0.12 | ||
统计值 | 35.906 | 19.512 | 1.781 | 1.215 | 6.205 | ||||
P值 | <0.001 | <0.001 | 0.077 | 0.226 | <0.001 | ||||
匹配后 | |||||||||
感染组 | 29(60.42) | 19(39.58) | 14(29.17) | 34(70.83) | 13.52±4.71 | 3.85±1.61 | 0.46±0.16 | ||
未感染组 | 10(20.83) | 38(79.17) | 1(2.08) | 47(97.92) | 12.42±3.99 | 4.29±2.50 | 0.31±0.11 | ||
统计值 | 15.59 | 13.353 | 1.235 | 1.025 | 5.352 | ||||
P值 | <0.001 | <0.001 | 0.22 | 0.308 | <0.001 |
项目 | 预测模型一 | 预测模型二 | |||
---|---|---|---|---|---|
OR①值(95%CI②) | P值 | OR①值(95%CI②) | P值 | ||
PROM到分娩时间 | 3.987(1.659~5.253) | 0.021 | 2.846(2.351~3.478) | 0.003 | |
阴道指检次数 | 4.654(2.897~6.375) | 0.016 | 3.022(2.557~3.461) | 0.013 | |
产前使用抗菌药物 | 1.542(1.149~2.389) | 0.063 | 1.369(1.207~2.526) | 0.066 | |
5 min Apgar评分 | 1.067(1.003~2.643) | 0.073 | 1.075(1.003~2.292) | 0.081 | |
羊水污染 | 1.291(1.143~2.543) | 0.078 | 1.673(1.381~2.864) | 0.069 | |
绒毛膜羊膜炎 | 1.941(1.532~2.191) | 0.017 | 3.042(2.783~3.576) | 0.006 | |
CD64指数≥0.40 | 7.056(3.659~8.953) | 0.001 | |||
GBS阳性 | 4.675(2.563~6.398) | 0.012 |
项目 | 预测模型一 | 预测模型二 | |||
---|---|---|---|---|---|
OR①值(95%CI②) | P值 | OR①值(95%CI②) | P值 | ||
PROM到分娩时间 | 3.987(1.659~5.253) | 0.021 | 2.846(2.351~3.478) | 0.003 | |
阴道指检次数 | 4.654(2.897~6.375) | 0.016 | 3.022(2.557~3.461) | 0.013 | |
产前使用抗菌药物 | 1.542(1.149~2.389) | 0.063 | 1.369(1.207~2.526) | 0.066 | |
5 min Apgar评分 | 1.067(1.003~2.643) | 0.073 | 1.075(1.003~2.292) | 0.081 | |
羊水污染 | 1.291(1.143~2.543) | 0.078 | 1.673(1.381~2.864) | 0.069 | |
绒毛膜羊膜炎 | 1.941(1.532~2.191) | 0.017 | 3.042(2.783~3.576) | 0.006 | |
CD64指数≥0.40 | 7.056(3.659~8.953) | 0.001 | |||
GBS阳性 | 4.675(2.563~6.398) | 0.012 |
模型 | χ2值 | 自由度 | P值 |
---|---|---|---|
预测模型一 | 6.247 | 10 | 0.826 |
预测模型二 | 5.225 | 10 | 0.937 |
模型 | χ2值 | 自由度 | P值 |
---|---|---|---|
预测模型一 | 6.247 | 10 | 0.826 |
预测模型二 | 5.225 | 10 | 0.937 |
CD64指数 | GBS阳性 | 单因素分析 | 多因素分析 | |||
---|---|---|---|---|---|---|
OR值(95%CI) | P值 | OR值(95%CI) | P值 | |||
无 | 无 | 1.000 | 1.000 | |||
有 | 无 | 1.351(1.214~2.041) | 0.011 | 1.948(1.149~2.258) | 0.001 | |
无 | 有 | 2.423(1.336~3.614) | <0.001 | 2.368(1.515~3.248) | 0.023 | |
有 | 有 | 4.297(2.347~8.645) | 0.000 | 4.977(1.488~5.279) | 0.014 |
CD64指数 | GBS阳性 | 单因素分析 | 多因素分析 | |||
---|---|---|---|---|---|---|
OR值(95%CI) | P值 | OR值(95%CI) | P值 | |||
无 | 无 | 1.000 | 1.000 | |||
有 | 无 | 1.351(1.214~2.041) | 0.011 | 1.948(1.149~2.258) | 0.001 | |
无 | 有 | 2.423(1.336~3.614) | <0.001 | 2.368(1.515~3.248) | 0.023 | |
有 | 有 | 4.297(2.347~8.645) | 0.000 | 4.977(1.488~5.279) | 0.014 |
预测指标 | 曲线下面积(95%CI) | P值 | 特异性/% | 敏感性/% | 阳性预测值/% | 阴性预测值/% |
---|---|---|---|---|---|---|
CD64指数 | 0.763(0.741~0.823) | <0.001 | 79.65 | 78.95 | 84.82 | 69.25 |
GBS阳性 | 0.807(0.753~0.853) | <0.001 | 79.42 | 79.35 | 85.64 | 70.93 |
二者联合 | 0.847(0.779~0.869) | <0.001 | 81.37 | 82.48 | 89.92 | 80.56 |
预测指标 | 曲线下面积(95%CI) | P值 | 特异性/% | 敏感性/% | 阳性预测值/% | 阴性预测值/% |
---|---|---|---|---|---|---|
CD64指数 | 0.763(0.741~0.823) | <0.001 | 79.65 | 78.95 | 84.82 | 69.25 |
GBS阳性 | 0.807(0.753~0.853) | <0.001 | 79.42 | 79.35 | 85.64 | 70.93 |
二者联合 | 0.847(0.779~0.869) | <0.001 | 81.37 | 82.48 | 89.92 | 80.56 |
[1] |
LORTHE E, LETOUZEY M, TORCHIN H, et al. Antibiotic prophylaxis in preterm premature rupture of membranes at 24-31 weeks' gestation:perinatal and 2-year outcomes in the EPIPAGE-2 cohort[J]. BJOG, 2022, 129(9):1560-1573.
DOI URL |
[2] | MOTOMURA K, ROMERO R, XU Y, et al. Intra-amniotic infection with ureaplasma parvum causes preterm birth and neonatal mortality that are prevented by treatment with clarithromycin[J]. mBio, 2020, 11(3):e00797-e00820. |
[3] | RONZONI S, COBO T, D'SOUZA R, et al. Individualized treatment of preterm premature rupture of membranes to prolong the latency period,reduce the rate of preterm birth,and improve neonatal outcomes[J]. Am J Obstet Gynecol, 2022, 227(2):296.e1-296.e18. |
[4] |
OLBRICH P, ORTIZ ALJARO P, FREEMAN A F. Eosinophilia associated with immune deficiency[J]. J Allergy Clin Immunol Pract, 2022, 10(5):1140-1153.
DOI URL |
[5] | 许明峰, 程锐, 冯罗华. 脐带血中性粒细胞CD64指数在诊断胎膜早破新生儿感染中的价值[J]. 实用临床医药杂志, 2017, 21(15):130-131. |
[6] | 中华医学会妇产科学分会产科学组. 胎膜早破的诊断与处理指南(2015)[J]. 中华妇产科杂志, 2015, 50(1):3-8. |
[7] | 邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 4版. 北京: 人民卫生出版社, 2019. |
[8] |
LENDE M N, MORRIS B A, LYNCH T A. Implementing american college of obstetricians and gynecologists outpatient antepartum testing recommendations:can your clinic handle it?[J]. Am J Perinatol, 2023, 40(7):711-717.
DOI URL |
[9] | 尚红, 王毓三, 申子瑜. 全国临床检验操作规程[M]. 4版. 北京: 人民卫生出版社, 2014. |
[10] |
HIRATA K, UEDA K, WADA K, et al. Pregnancy outcomes after preterm premature rupture of membranes:the Japan environment and children's study[J]. J Obstet Gynaecol Res, 2022, 48(11):2756-2765.
DOI URL |
[11] |
WANG S, ZOU F, WU S, et al. Neurotrophic factor levels in the serum and cerebrospinal fluid of neonates infected with human cytomegalovirus[J]. Microbiol Immunol, 2021, 65(9):373-382.
DOI URL |
[12] |
SUN Q, GAO Y, QIAO L, et al. 25(OH)-Vitamin D alleviates neonatal infectious pneumonia via regulating TGFβ-mediated nuclear translocation mechanism of YAP/TAZ[J]. Bioengineered, 2021, 12(1):8931-8942.
DOI PMID |
[13] |
NARAMURA T, IMAMURA H, YOSHIMATSU H, et al. The predictive value of procalcitonin and high-sensitivity C-reactive protein for early bacterial infections in preterm neonates[J]. Neonatology, 2021, 118(1):28-36.
DOI URL |
[14] |
JANŽI L, REPAS J, PAVLIN M, et al. Macrophage polarization during Streptococcus agalactiae infection is isolate specific[J]. Front Microbiol, 2023, 14:1186087.
DOI URL |
[15] |
MÜLLER H, STÄHLING A C, BRUNS N, et al. Latency duration of preterm premature rupture of membranes and neonatal outcome:a retrospective single-center experience[J]. Eur J Pediatr, 2022, 181(2):801-811.
DOI |
[16] |
BECK C, GALLAGHER K, TAYLOR L A, et al. Chorioamnionitis and risk for maternal and neonatal sepsis:a systematic review and meta-analysis[J]. Obstet Gynecol, 2021, 137(6):1007-1022.
DOI URL |
[17] |
SPRONG K E, MABENGE M, WRIGHT C A, et al. Ureaplasma species and preterm birth:current perspectives[J]. Crit Rev Microbiol, 2020, 46(2):169-181.
DOI URL |
[18] |
YUAN X Y, LIU H Z, LIU J F, et al. Pathogenic mechanism,detection methods and clinical significance of group B Streptococcus[J]. Future Microbiol, 2021, 16:671-685.
DOI URL |
[19] | 方雪, 马莱超, 隋红梅. B族链球菌孕晚期分离株耐药、毒力基因分布及其对肠道菌群、妊娠结局的影响[J]. 中华医院感染学杂志, 2023, 33(1):105-109. |
[20] | 祝垚, 高磊, 黄仲玲, 等. 新生儿B族链球菌感染现状的多中心前瞻性研究[J]. 中国当代儿科杂志, 2021, 23(9):889-895. |
[21] | 王婷婷, 薛飞扬, 綦萍, 等. 妊娠晚期孕妇生殖道B族链球菌感染对并发胎膜早破与新生儿感染、围生结局影响[J]. 中国计划生育学杂志, 2022, 30(6):1348-1351. |
[22] |
ADHISIVAM B. Maternal colonization of group B Streptococcus and neonatal sepsis[J]. Indian J Pediatr, 2022, 89(12):1171-1172.
DOI |
[1] | GUO Shuli, LUO Xiandao, JIA Haiying, YANG Liwei, HUANG Guohong, WANG Changmin. Analysis of co-infection of GBS and Mycoplasma in perinatal women [J]. Laboratory Medicine, 2020, 35(5): 451-454. |
[2] | MA Caiyan, LAI Wenqiang, CHEN Xiaoping. Roles of PCT,HNL and CD64 in the diagnosis of bacterial infection [J]. Laboratory Medicine, 2019, 34(5): 433-436. |
[3] | CHEN Xiaoping, WANG Huijiao, YU Beiwei, XU Jiaojun, XU Qiulian, ZHAO Lan, XU Xiaobao, DING Mingxing. Group B Streptococcus screen in prevention and control of maternal and neonatal infection [J]. Laboratory Medicine, 2016, 31(4): 266-269. |
[4] | ZHANG Jinghua, YUAN Yinghua, CHENG Jie, SUN Fenyong. Evaluation on the detection methods of group B Streptococcus in late pregnancy [J]. Laboratory Medicine, 2016, 31(11): 974-977. |
[5] | LU Tingyan, SHEN Li, TANG Zhenhua. Evaluation on the efficiency of different media and GBS enrichment broth for GBS detection [J]. Laboratory Medicine, 2015, 30(9): 890-893. |
[6] | JI Xiuqing, LU Gensheng, HU Ping, CHENG Jian, LIU Ye, LIN Ying. Colonization of group B Streptococcus in late pregnancy by fluorescence quantitation PCR in Nanjing area [J]. , 2014, 29(6): 628-630. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||